biotrust glp 1 elevate GLP1 Elevate™ - GLP-1 Booster Supplement | Curb Cravings & Support Metabolic Health | Increase Natural Production with Clinically Studied Ingredients Relesium™ GLP-1 Digestive Support Vanilla

Description

Surrogacy involves regular appointments, injections, and blood draws

This means 52 injections per year

Different Marketing Claims Wegovy was aggressively marketed directly to consumers for weight loss Ozempic marketing technically focused on diabetes but implied weight benefits Social media influencers promoted both (often Ozempic off-label) Marketing materials affect what representations were made to you Example Case Scenarios Scenario A: Type 2 Diabetic on Ozempic Patient: 58-year-old with 10-year diabetes history Prescription: Ozempic 1.0 mg weekly for A1C control Result: Developed severe gastroparesis requiring feeding tube Legal claim: Even for approved use, warnings about gastroparesis were inadequate Scenario B: Weight Loss Patient on Ozempic (Off-Label) Patient: 42-year-old seeking to lose 40 pounds, no diabetes Prescription: Ozempic 2.0 mg (prescribed off-label by weight loss clinic) Result: Chronic vomiting, diagnosed with gastroparesis Legal claim: Off-label promotion and inadequate warnings for weight-loss use Scenario C: Obesity Patient on Wegovy Patient: 35-year-old with BMI 38, prescribed for weight management Prescription: Wegovy escalated to 2.4 mg Result: Intestinal blockage requiring emergency surgery Legal claim: Despite approved use, risks were not adequately disclosed All three scenarios may have valid legal claims , but the specific arguments and evidence will differ

The most recent international guidelines recommend that when discussing the use of GLP-1 RA with women with PCOS, the potential side effects and the need for long-term use in weight management should always be considered in the shared decision making with the patient